Cargando…

The novel dual GC-A and GC-B designer natriuretic peptide, cenderitide (CD-NP), enhances the renal actions of furosemide in a model of severe heart failure

Detalles Bibliográficos
Autores principales:	Costello-Boerrigter, Lisa C, Boerrigter, Guido, Mangiafico, Sarah, Cataliotti, Alessandro, Burnett, John C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363209/ http://dx.doi.org/10.1186/1471-2210-11-S1-P17

Ejemplares similares

Bioavailability of intravenous versus subcutaneous administration of the dual GC-A and GC-B designer natriuretic peptide cenderitide in healthy canines
por: Boerrigter, Guido, et al.
Publicado: (2011)

Activation of heme-free soluble guanylate cyclase with cinaciguat has beneficial cardiorenal actions when added to furosemide in experimental heart failure
por: Boerrigter, Guido, et al.
Publicado: (2011)

Cenderitide (CD-NP), a novel peptide designed to activate both guanylyl cyclase B and A, activates the second messenger cGMP, suppresses aldosterone, and preserves GFR without reducing blood pressure in a proof-of-concept study in patients with chronic heart failure
por: Costello-Boerrigter, Lisa C, et al.
Publicado: (2011)

Pro-B-Type natriuretic peptide: a novel, specific biomarker for detection of left ventricular dysfunction in the general community
por: Macheret, Fima, et al.
Publicado: (2009)

Cenderitide, a novel dual GC-A and GC-B receptor activator, is a potent chronic cardiorenal fibroinhibiting peptide which suppresses aldosterone and reduces proteinuria in models of ardiorenal fibrosis
por: Martin, Fernando L, et al.
Publicado: (2011)

Cardiac Natriuretic Peptides: Contributors to Cardiac Cachexia or Possible Anti-obesity Agents or Both?
por: Costello-Boerrigter, Lisa C.
Publicado: (2012)

Effects of long-term proBNP cardiac gene delivery in experimental hypertensive heart disease
por: Cataliotti, Alessandro, et al.
Publicado: (2011)

B-type natriuretic peptide single nucleotide polymorphism rs198389 and survival in the general community
por: Boerrigter, Guido, et al.
Publicado: (2009)

B-type natriuretic peptide single nucleotide polymorphism rs198389 is highly prevalent and impacts test characteristics of common assays
por: Costello-Boerrigter, Lisa C, et al.
Publicado: (2009)

Cenderitide-Eluting Film for Potential Cardiac Patch Applications
por: Ng, Xu Wen, et al.
Publicado: (2013)

Chronic natriuretic peptide protein therapeutics
por: Chen, Horng H, et al.
Publicado: (2013)

Tissue- and development-specific glycosylation states of the natriuretic peptide receptors guanylyl cyclase-A (GC-A) and GC-B
por: Müller, Dieter, et al.
Publicado: (2011)

Divergent effects of a designer natriuretic peptide CD-NP in the regulation of adipose tissue and metabolism
por: Glöde, Anja, et al.
Publicado: (2017)

AC-NP: A Novel Chimeric Peptide with Natriuretic and Vasorelaxing Actions
por: Chen, Bao-Ying, et al.
Publicado: (2011)

Natriuretic Peptide Signaling via Guanylyl Cyclase (GC)-A: An Endogenous Protective Mechanism of the Heart
por: Kishimoto, Ichiro, et al.
Publicado: (2009)

M-atrial natriuretic peptide and nitroglycerin in experimental acute hypertensive heart failure: differential actions of two cGMP activating therapeutics
por: McKie, Paul M, et al.
Publicado: (2013)

Protective role of endogenous cardiac natriuretic peptide/GC-A system on the maternal heart during the postpartum period
por: Otani, Kentaro, et al.
Publicado: (2013)

A novel designer natriuretic peptide CD-NP suppresses TGF-beta 1 induced collagen Type I production in human cardiac fibroblasts
por: Ichiki, Tomoko, et al.
Publicado: (2009)

M‐Atrial Natriuretic Peptide and Nitroglycerin in a Canine Model of Experimental Acute Hypertensive Heart Failure: Differential Actions of 2 cGMP Activating Therapeutics
por: McKie, Paul M., et al.
Publicado: (2014)

Krait natriuretic peptide (KNP): a non-classical NP
por: Sridharan, Sindhuja, et al.
Publicado: (2013)

CD-NP: A Novel Engineered Dual Guanylyl Cyclase Activator with Anti-Fibrotic Actions in the Heart
por: Martin, Fernando L., et al.
Publicado: (2012)

Functions of NO-GC1 and NO-GC2 in pain processing
por: Petersen, Jonas, et al.
Publicado: (2015)

Global Urinary Volatolomics with (GC×)GC-TOF-MS
por: Myridakis, Antonis, et al.
Publicado: (2023)

Treatment with CBA-NP a novel chimeric natriuretic peptide attenuates cardiorenal fibrosis and improves diastolic dysfunction in diabetic rat model
por: Ameenuddin, Syed, et al.
Publicado: (2011)

Mutation of three amino acids in the disulfide-ring of a CNP based chimeric natriuretic peptide alters its vascular properties
por: Chen, Horng H, et al.
Publicado: (2009)

A biodegradable in-situ polymer precipitation delivery system for sustained delivery of a novel chimeric natriuretic peptide CD-NP in an experimental model of myocardial infarction
por: Lim, Soo Ghim, et al.
Publicado: (2013)

Schematic for efficient computation of GC, GC3, and AT3 bias spectra of genome
por: Rizvi, Ahsan Z, et al.
Publicado: (2012)

Improvement of Ylang-Ylang Essential Oil Characterization by GC×GC-TOFMS
por: Brokl, Michał, et al.
Publicado: (2013)

Analysis of Volatile Compounds in Pears by HS-SPME-GC×GC-TOFMS
por: Wang, Chenchen, et al.
Publicado: (2019)

A Human Study to Evaluate Safety, Tolerability, and Cyclic GMP Activating Properties of Cenderitide in Subjects With Stable Chronic Heart Failure
por: Kawakami, Rika, et al.
Publicado: (2018)

Elevated Concentrations of 4-Bromobiphenyl and 1,3,5-Tribromobenzene Found in Deep Water of Lake Geneva Based on GC×GC-ENCI-TOFMS and GC×GC-μECD
por: Samanipour, Saer, et al.
Publicado: (2017)

Natriuretic peptides, via GC-A/cGMP, moderate hypoxia-induced VEGF release from astrocytes and thereby pathological neovascularization in the retina
por: Spiranec, Katarina, et al.
Publicado: (2015)

Application of GC–TOF/MS and GC×GC–TOF/MS to Discriminate Coffee Products in Three States (Bean, Powder, and Brew)
por: Fang, Xiaolei, et al.
Publicado: (2023)

Innovative Therapeutics: Designer Natriuretic Peptides
por: Meems, Laura M.G., et al.
Publicado: (2016)

C-Type natriuretic peptide: a potential urinary biomarker for renal remodeling and fibrosis during aging
por: Sangaralingham, Jeson S, et al.
Publicado: (2011)

GC–MS and GC–NPD Determination of Formaldehyde Dimethylhydrazone in Water Using SPME
por: Kenessov, Bulat, et al.
Publicado: (2011)

Characterization of Volatile Compounds in Four Different Rhododendron Flowers by GC×GC-QTOFMS
por: Qian, Chen-Yu, et al.
Publicado: (2019)

GC bias affects genomic and metagenomic reconstructions, underrepresenting GC-poor organisms
por: Browne, Patrick Denis, et al.
Publicado: (2020)

Application of Chemometrics for Coal Pyrolysis Products by Online py-GC×GC–MS
por: Yin, Hao, et al.
Publicado: (2021)

Searching for Potential Markers of Glomerulopathy in Urine by HS-SPME-GC×GC TOFMS
por: Ligor, Tomasz, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n4oh9fa8m3pofutrj2k652m29m